Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucose containing oral rehydration solution is an isotonic fluid preparation containing water, glucose, and electrolytes, principally sodium chloride and sometimes sodium bicarbonate or citrate. Its mechanism of action takes advantage of the sodium-glucose co-transport in the intestines, where glucose facilitates optimal sodium and water absorption from the gut into the systemic circulation. This solution is primarily indicated for treating and preventing dehydration due to diarrheal fluid losses, high output stoma, enterocutaneous fistula, short bowel syndrome, or intestinal failure. It is used to restore and maintain fluid and electrolyte balance and can be formulated at home or provided in commercial powder or premixed liquid forms. The World Health Organization’s recommended formula includes sodium chloride, sodium citrate (or bicarbonate), potassium chloride, and glucose, but glucose-containing ORS formulations may exclude potassium for specific clinical indications[1][3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucose containing oral rehydration solution.